申请人:Pfizer Inc
公开号:US05639752A1
公开(公告)日:1997-06-17
Compounds of the formula ##STR1## wherein Z is ##STR2## R.sub.1 is ##STR3## X is O, NH, or S; A, B, D, E, and F are each independently C, N, O, or S; wherein the remaining variables are defined in the specification, and the pharmaceutically acceptable salts thereof. These compounds are useful psychotherapeutics and are potent serotonin (5-HT.sub.1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
该公式化合物为##STR1##,其中Z为##STR2##,R.sub.1为##STR3##,X为O、NH或S;A、B、D、E和F分别独立地为C、N、O或S;其余变量在说明书中有定义,以及其药用盐。这些化合物是有用的精神治疗药物,是有效的5-羟色胺(5-HT.sub.1)激动剂,可用于治疗抑郁症、焦虑症、进食障碍、肥胖症、药物滥用、簇状头痛、偏头痛、疼痛、慢性阵发性半头痛和与血管疾病相关的头痛,以及其他由5-羟色胺能神经传导不足引起的疾病。这些化合物还可用作中枢作用的降压药和扩血管药。